Azooka Labs unveils Safe MTM to Store COVID-19 Samples at Room Temperature for up to a week
15 Dezember 2020 - 1:00AM
JCN Newswire (English)
Molecular Transport Medium at the price of
VTM
|
BANGALORE, INDIA, Dec 15, 2020 - (ACN Newswire) - Azooka Labs,
a leading safe fluorophore company with specialization in Molecular
Biology products, reveals its first range of novel COVID-19
diagnostics products. RNA Wrapr is a molecular transport medium for
COVID-19 sample collection, developed as part of the COVID-19
response team from Indian Institute of Science.
|
Molecular Transport Media
that inactivates the Coronavirus immediately. Not only that!
Azooka's RNA Wrapr does not require dry ice for storage and can be
processed until a week. A storage medium for COVID-19 that is safe,
easy to use and affordable. (RNA Wrapr comes in 3ml or 10ml vials
with Fluccoluated Nylon Nasal Swabs. Price starts at INR 99 per
vial.) |
RNA Wrapr inactivates the virus immediately only preserving DNA/RNA
content required for RT-PCR tests. The sample tubes can be stored
up to 7 days in Room Temperature and transported without dry ice or
gel packs. RNA Wrapr is safe to handle even during unexpected
accidental spillage or handling errors. Developing countries can
collect samples in centers without BSL2 or BSL3 certifications.
Azooka's RNA Wrapr is priced at INR 99 in India, aligned with the
price of one litre of petrol, to help the diagnostic centers
upgrade from VTM to MTM. Azooka plans to enter the APAC market
through partners with $9 and $6 pricing plans per test.
"Azooka has actively been a part of the fight against COVID by
developing PCR and RT PCR kits with support from Dept of
Biotechnology and Elevate Karnataka even before the pandemic hit
us," quoted Alex D Paul, CEO, Azooka Labs. He further added, "MTM
has ensured safety and security of COVID-19 samples to be stored at
Room Temperature for up to seven days".
"Azooka is the only startup from India working to replace
Carcinogenic and Mutagenic SYBR dyes widely used in RUO and
Diagnostics reagents. Safety and cost savings needed for COVID
crisis management today are the highlights of Azooka's MTM," says
Dr. C V Natraj, former SVP, Corporate Research, Unilever plc.
"Azooka is striving to provide a safer molecular grade transport
medium that is at sub Rs. 100. We are appealing to a segment of
users, who care about the safety of their frontline health care
workers," stated Dr. Fatima Benazir, Co-founder & CSO, Azooka
Labs.
About Azooka Labs
Azooka is a patented fluorophore company focused on developing safe
biotech consumables at a price affordable for all countries across
the globe. Azooka's first diagnostics product RNA Wrapr- molecular
transport medium, is approved by ICMR and certified by CE. Azooka
is an IISc invested startup based in Bengaluru with R&D unit at
the Indian Institute of Science and manufacturing facility in
Peenya Industrial Area, Karnataka.
Azooka was recently awarded the 'Best Women-Led Enterprise' at
StartUp India 2020. Azooka is open for licensing and partnerships
worldwide. Governments and Health Organizations can directly
contact Azooka for COVID-19 Crisis Management. For more information
visit: http://azooka.life/ and for the prices visit:
https://azooka.life/rna-wrapr-molecular-transport-medium/
Media Contact:
Alex D Paul, CEO
+91-9108424562
alx@azooka.life
Source: Azooka Labs
Copyright 2020 ACN Newswire . All rights reserved. |
Unilever (EU:UNA)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Unilever (EU:UNA)
Historical Stock Chart
Von Apr 2023 bis Apr 2024